Aveanna Healthcare  Inc. logo

Aveanna Healthcare Inc.

AVAH | NASDAQ
Chart Builder DCF Calculator
$13.44
-$0.23 (-1.68%)
At close: Sep 21, 2026, 4:00 PM ET
$13.55
+$0.11 (+0.82%)
Pre-market: Sep 22, 2026, 7:54 AM ET

Market Data

Market Cap
$2.93B
Enterprise Value
$4.33B
Beta
1.97
Average Volume
2.41M
Shares Outstanding (Diluted)
224.86M
Shares Change YoY
6.85%
Institutional Ownership
92.22%
Exchange
NASDAQ
ISIN
US05356F1057

Price Performance

Price Change 1M
0.3%
Price Change 3M
63.9%
Price Change 6M
103.0%
Price Change YTD
66.3%
Price Change 1Y
60.0%
Price Change 3Y
983.9%
Price Change 5Y
64.9%
1M CAGR (ann.)
41.6%
1Y CAGR (ann.)
58.9%
5Y CAGR (ann.)
8.4%
All-Time CAGR
2.1%

Valuation

PE Ratio
10.67
Forward PE
16.50
PEG Ratio
0.01
Forward PEG
1.00
PS Ratio
1.12
Forward PS
1.10
PB Ratio
10.19
P/FCF Ratio
17.65
P/Adj. FCF Ratio
16.46
P/OCF Ratio
17.45
EV/Sales
1.67
EV/EBIT
15.55
EV/EBITDA
14.49
EV/FCF
26.14
Earnings Yield
9.4%
FCF Yield
5.7%
Adj. FCF Yield
6.1%

Financial Health

Net Debt
$1.37B
Total Debt
$1.51B
Cash & Short-Term Investments
$97.2M
Total Assets
$2.11B
Current Ratio
1.16
Quick Ratio
1.16
Debt / Equity Ratio
5.24
Debt / EBITDA
5.03
Debt / FCF
9.08
OCF / Debt
0.11
Interest Coverage
2.32
Altman Z-Score
1.96
Piotroski F-Score
6

Margins & Profitability

Gross Profit Margin
31.9%
Operating Profit Margin
11.1%
EBITDA Margin
11.5%
Net Profit Margin
10.6%
FCF Margin
6.4%
Adj. FCF Margin
6.8%
SBC / Revenue
-0.5%
SBC Impact (per share)
-7.2%

Returns

Return on Assets
13.0%
Return on Equity
150.2%
Return on Invested Capital
15.3%
Return on Capital Employed
17.1%
Return on Tangible Assets
37.6%

Historical Growth (CAGR)

Revenue CAGR 3Y
12.4%
Revenue CAGR 5Y
9.7%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
426.5%
EPS CAGR 5Y
138.3%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
91.7%
FCF CAGR 5Y
60.5%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
12
EPS Growth Next 3Y
-8.5%
Revenue Growth Next 3Y
5.6%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
$0.20
EPS Growth Est (next Q)
33.3%
Revenue Est (next Q)
$679.51M
Revenue Growth Est (next Q)
9.3%

Fair Value Estimates

Graham Number
$6.12
Graham Upside
-54.5%
Lynch Fair Value
$31.50
Lynch Upside
134.4%
Price Target
$14.38
Price Target Upside
7.0%

Cash Flow

Operating Cash Flow
$168.2M
Free Cash Flow
$165.83M
Adj. Free Cash Flow
$177.83M
FCF Per Share
$0.76
OCF Per Share
$0.77
OCF/S Ratio
6.5%

Income Statement

Revenue
$2.6B
Gross Profit
$831.71M
Operating Income
$289.47M
EBITDA
$299.15M
Net Income
$274.76M
EPS (Diluted)
$1.26
Revenue / Employee
$73.32K
Profit / Employee
$7.74K
Employees
35,500

© 2026 bestshares.com. All rights reserved.